APO Research
Talk to an analyst

APO RESEARCH · REPORT

Free Fatty Acid Receptor 4

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Free Fatty Acid Receptor 4 Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchFree Fatty Acid Receptor 4 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Free Fatty Acid Receptor 4 Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Free Fatty Acid Receptor 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Free Fatty Acid Receptor 4 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Free Fatty Acid Receptor 4 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Free Fatty Acid Receptor 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Free Fatty Acid Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Free Fatty Acid Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Free Fatty Acid Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Free Fatty Acid Receptor 4 include Advinus Therapeutics Ltd, CymaBay Therapeutics Inc, Dompe Farmaceutici SpA, Sancilio & Company Inc, AstraZeneca Plc, GlaxoSmithKline Plc and Merck & Co Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Free Fatty Acid Receptor 4 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Free Fatty Acid Receptor 4 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Free Fatty Acid Receptor 4 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Free Fatty Acid Receptor 4.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Free Fatty Acid Receptor 4 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Free Fatty Acid Receptor 4 Market by Company

Advinus Therapeutics Ltd

CymaBay Therapeutics Inc

Dompe Farmaceutici SpA

Sancilio & Company Inc

AstraZeneca Plc

GlaxoSmithKline Plc

Merck & Co Inc

Free Fatty Acid Receptor 4 Segment by Type

SC-410

GSK-137647A

CB-001

Others

Free Fatty Acid Receptor 4 Segment by Application

Non Alcoholic Fatty Liver Disease

Metabolic Disorders

Type 2 Diabets

Others

Free Fatty Acid Receptor 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Free Fatty Acid Receptor 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Free Fatty Acid Receptor 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Free Fatty Acid Receptor 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Free Fatty Acid Receptor 4 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Free Fatty Acid Receptor 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of SC-410 Table 2. Major Company of GSK-137647A Table 3. Major Company of CB-001 Table 4. Major Company of Others Table 5. Global Free Fatty Acid Receptor 4 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (W Units) Table 7. Global Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Free Fatty Acid Receptor 4 Sales Market Share in Value by Type (2021-2026) Table 10. Global Free Fatty Acid Receptor 4 Price by Type (2021-2026) & (US$/Unit) Table 11. Global Free Fatty Acid Receptor 4 Sales by Type (2027-2032) & (W Units) Table 12. Global Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Free Fatty Acid Receptor 4 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Free Fatty Acid Receptor 4 Sales Market Share in Value by Type (2027-2032) Table 15. Global Free Fatty Acid Receptor 4 Price by Type (2027-2032) & (US$/Unit) Table 16. North America Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (W Units) Table 17. North America Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (W Units) Table 19. Europe Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (W Units) Table 23. Latin America Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Type (2021-2026) & (US$ Million) Table 26. Free Fatty Acid Receptor 4 Industry Trends Table 27. Free Fatty Acid Receptor 4 Industry Drivers Table 28. Free Fatty Acid Receptor 4 Industry Opportunities and Challenges Table 29. Free Fatty Acid Receptor 4 Industry Restraints Table 30. Global Free Fatty Acid Receptor 4 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Free Fatty Acid Receptor 4 Revenue Market Share by Company (2021-2026) Table 32. Global Free Fatty Acid Receptor 4 Sales by Company (2021-2026) & (W Units) Table 33. Global Free Fatty Acid Receptor 4 Sales Share by Company (2021-2026) Table 34. Global Free Fatty Acid Receptor 4 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Free Fatty Acid Receptor 4 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Free Fatty Acid Receptor 4 Major Company Production Sites and Headquarters Table 37. Global Free Fatty Acid Receptor 4 Company, Product Type & Application Table 38. Global Free Fatty Acid Receptor 4 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Free Fatty Acid Receptor 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Free Fatty Acid Receptor 4 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Free Fatty Acid Receptor 4 Sales by Region (2021-2026) & (W Units) Table 43. Global Free Fatty Acid Receptor 4 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Free Fatty Acid Receptor 4 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Free Fatty Acid Receptor 4 Sales Market Share in Value by Region (2021-2026) Table 46. Global Free Fatty Acid Receptor 4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Free Fatty Acid Receptor 4 Sales by Region (2027-2032) & (W Units) Table 48. Global Free Fatty Acid Receptor 4 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Free Fatty Acid Receptor 4 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Free Fatty Acid Receptor 4 Sales Market Share in Value by Region (2027-2032) Table 51. Global Free Fatty Acid Receptor 4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Free Fatty Acid Receptor 4 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (W Units) Table 54. Global Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Free Fatty Acid Receptor 4 Sales Market Share in Value by Application (2021-2026) Table 57. Global Free Fatty Acid Receptor 4 Price by Application (2021-2026) & (US$/Unit) Table 58. Global Free Fatty Acid Receptor 4 Sales by Application (2027-2032) & (W Units) Table 59. Global Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Free Fatty Acid Receptor 4 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Free Fatty Acid Receptor 4 Sales Market Share in Value by Application (2027-2032) Table 62. Global Free Fatty Acid Receptor 4 Price by Application (2027-2032) & (US$/Unit) Table 63. North America Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (W Units) Table 64. North America Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (W Units) Table 66. Europe Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (W Units) Table 70. Latin America Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Application (2021-2026) & (US$ Million) Table 73. Advinus Therapeutics Ltd Company Information Table 74. Advinus Therapeutics Ltd Business Overview Table 75. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Product Portfolio Table 77. Advinus Therapeutics Ltd Recent Development Table 78. CymaBay Therapeutics Inc Company Information Table 79. CymaBay Therapeutics Inc Business Overview Table 80. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Product Portfolio Table 82. CymaBay Therapeutics Inc Recent Development Table 83. Dompe Farmaceutici SpA Company Information Table 84. Dompe Farmaceutici SpA Business Overview Table 85. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Product Portfolio Table 87. Dompe Farmaceutici SpA Recent Development Table 88. Sancilio & Company Inc Company Information Table 89. Sancilio & Company Inc Business Overview Table 90. Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sancilio & Company Inc Free Fatty Acid Receptor 4 Product Portfolio Table 92. Sancilio & Company Inc Recent Development Table 93. AstraZeneca Plc Company Information Table 94. AstraZeneca Plc Business Overview Table 95. AstraZeneca Plc Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Plc Free Fatty Acid Receptor 4 Product Portfolio Table 97. AstraZeneca Plc Recent Development Table 98. GlaxoSmithKline Plc Company Information Table 99. GlaxoSmithKline Plc Business Overview Table 100. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Product Portfolio Table 102. GlaxoSmithKline Plc Recent Development Table 103. Merck & Co Inc Company Information Table 104. Merck & Co Inc Business Overview Table 105. Merck & Co Inc Free Fatty Acid Receptor 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Merck & Co Inc Free Fatty Acid Receptor 4 Product Portfolio Table 107. Merck & Co Inc Recent Development Table 108. North America Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 109. North America Free Fatty Acid Receptor 4 Sales by Country (2021-2026) & (W Units) Table 110. North America Free Fatty Acid Receptor 4 Sales Market Share by Country (2021-2026) Table 111. North America Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032) & (W Units) Table 112. North America Free Fatty Acid Receptor 4 Sales Market Share Forecast by Country (2027-2032) Table 113. North America Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Free Fatty Acid Receptor 4 Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Free Fatty Acid Receptor 4 Market Share by Country (2021-2026) Table 116. North America Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Free Fatty Acid Receptor 4 Market Share Forecast by Country (2027-2032) Table 118. Europe Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. Europe Free Fatty Acid Receptor 4 Sales by Country (2021-2026) & (W Units) Table 120. Europe Free Fatty Acid Receptor 4 Sales Market Share by Country (2021-2026) Table 121. Europe Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032) & (W Units) Table 122. Europe Free Fatty Acid Receptor 4 Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Free Fatty Acid Receptor 4 Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Free Fatty Acid Receptor 4 Market Share by Country (2021-2026) Table 126. Europe Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Free Fatty Acid Receptor 4 Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Country (2021-2026) & (W Units) Table 130. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032) & (W Units) Table 132. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Free Fatty Acid Receptor 4 Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Free Fatty Acid Receptor 4 Market Share by Country (2021-2026) Table 136. Asia-Pacific Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Free Fatty Acid Receptor 4 Market Share Forecast by Country (2027-2032) Table 138. Latin America Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. Latin America Free Fatty Acid Receptor 4 Sales by Country (2021-2026) & (W Units) Table 140. Latin America Free Fatty Acid Receptor 4 Sales Market Share by Country (2021-2026) Table 141. Latin America Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032) & (W Units) Table 142. Latin America Free Fatty Acid Receptor 4 Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Free Fatty Acid Receptor 4 Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Free Fatty Acid Receptor 4 Market Share by Country (2021-2026) Table 146. Latin America Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Free Fatty Acid Receptor 4 Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Country (2021-2026) & (W Units) Table 150. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032) & (W Units) Table 152. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Free Fatty Acid Receptor 4 Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Free Fatty Acid Receptor 4 Market Share by Country (2021-2026) Table 156. Middle East and Africa Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Free Fatty Acid Receptor 4 Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Free Fatty Acid Receptor 4 Distributors List Table 161. Free Fatty Acid Receptor 4 Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Free Fatty Acid Receptor 4 Image Figure 2. Global Free Fatty Acid Receptor 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Free Fatty Acid Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 4. Global Free Fatty Acid Receptor 4 Sales (2021-2032) & (W Units) Figure 5. SC-410 Image Figure 6. Global SC-410 Sales YoY Growth (2021-2032) & (W Units) Figure 7. GSK-137647A Image Figure 8. Global GSK-137647A Sales YoY Growth (2021-2032) & (W Units) Figure 9. CB-001 Image Figure 10. Global CB-001 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Free Fatty Acid Receptor 4 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Free Fatty Acid Receptor 4 Market Share by Type 2025 VS 2032 Figure 15. North America Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type in 2025 Figure 16. North America Free Fatty Acid Receptor 4 Sales Market Share in Value by Type in 2025 Figure 17. Europe Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Free Fatty Acid Receptor 4 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Free Fatty Acid Receptor 4 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Free Fatty Acid Receptor 4 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Non Alcoholic Fatty Liver Disease Image Figure 28. Global Non Alcoholic Fatty Liver Disease Sales YoY Growth (2021-2032) & (W Units) Figure 29. Metabolic Disorders Image Figure 30. Global Metabolic Disorders Sales YoY Growth (2021-2032) & (W Units) Figure 31. Type 2 Diabets Image Figure 32. Global Type 2 Diabets Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Free Fatty Acid Receptor 4 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Free Fatty Acid Receptor 4 Market Share by Application 2025 VS 2032 Figure 37. North America Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application in 2025 Figure 38. North America Free Fatty Acid Receptor 4 Sales Market Share in Value by Application in 2025 Figure 39. Europe Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Free Fatty Acid Receptor 4 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Free Fatty Acid Receptor 4 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share in Value by Application in 2025 Figure 47. North America Free Fatty Acid Receptor 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Free Fatty Acid Receptor 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Free Fatty Acid Receptor 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Free Fatty Acid Receptor 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Free Fatty Acid Receptor 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Free Fatty Acid Receptor 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Free Fatty Acid Receptor 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Free Fatty Acid Receptor 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Free Fatty Acid Receptor 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Free Fatty Acid Receptor 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Free Fatty Acid Receptor 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Free Fatty Acid Receptor 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Free Fatty Acid Receptor 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Free Fatty Acid Receptor 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Free Fatty Acid Receptor 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Free Fatty Acid Receptor 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Free Fatty Acid Receptor 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Free Fatty Acid Receptor 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Free Fatty Acid Receptor 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Free Fatty Acid Receptor 4 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Free Fatty Acid Receptor 4 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • SC-410
  • GSK-137647A
  • CB-001
  • Others
Applications
  • Non Alcoholic Fatty Liver Disease
  • Metabolic Disorders
  • Type 2 Diabets
  • Others
Companies covered
  • Advinus Therapeutics Ltd
  • CymaBay Therapeutics Inc
  • Dompe Farmaceutici SpA
  • Sancilio & Company Inc
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Merck & Co Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Free Fatty Acid Receptor 4 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Free Fatty Acid Receptor 4 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Free Fatty Acid Receptor 4 Market by Type
  6. 1.3.1 SC-410
  7. 1.3.2 GSK-137647A
  8. 1.3.3 CB-001
  9. 1.3.4 Others
  10. 1.4 Global Free Fatty Acid Receptor 4 Market Size by Type
  11. 1.4.1 Global Free Fatty Acid Receptor 4 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Free Fatty Acid Receptor 4 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Free Fatty Acid Receptor 4 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Free Fatty Acid Receptor 4 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Free Fatty Acid Receptor 4 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Free Fatty Acid Receptor 4 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Free Fatty Acid Receptor 4 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Free Fatty Acid Receptor 4 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Free Fatty Acid Receptor 4 Industry Trends
  2. 2.2 Free Fatty Acid Receptor 4 Industry Drivers
  3. 2.3 Free Fatty Acid Receptor 4 Industry Opportunities and Challenges
  4. 2.4 Free Fatty Acid Receptor 4 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Free Fatty Acid Receptor 4 Revenue (2021-2026)
  2. 3.2 Global Top Players by Free Fatty Acid Receptor 4 Sales (2021-2026)
  3. 3.3 Global Top Players by Free Fatty Acid Receptor 4 Price (2021-2026)
  4. 3.4 Global Free Fatty Acid Receptor 4 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Free Fatty Acid Receptor 4 Major Company Production Sites & Headquarters
  6. 3.6 Global Free Fatty Acid Receptor 4 Company, Product Type & Application
  7. 3.7 Global Free Fatty Acid Receptor 4 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Free Fatty Acid Receptor 4 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Free Fatty Acid Receptor 4 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Free Fatty Acid Receptor 4 Tier 1, Tier 2, and Tier 3
4 Free Fatty Acid Receptor 4 Regional Status and Outlook
  1. 4.1 Global Free Fatty Acid Receptor 4 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Free Fatty Acid Receptor 4 Historic Market Size by Region
  3. 4.2.1 Global Free Fatty Acid Receptor 4 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Free Fatty Acid Receptor 4 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Free Fatty Acid Receptor 4 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Free Fatty Acid Receptor 4 Forecasted Market Size by Region
  7. 4.3.1 Global Free Fatty Acid Receptor 4 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Free Fatty Acid Receptor 4 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Free Fatty Acid Receptor 4 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Free Fatty Acid Receptor 4 by Application
  1. 5.1 Free Fatty Acid Receptor 4 Market by Application
  2. 5.1.1 Non Alcoholic Fatty Liver Disease
  3. 5.1.2 Metabolic Disorders
  4. 5.1.3 Type 2 Diabets
  5. 5.1.4 Others
  6. 5.2 Global Free Fatty Acid Receptor 4 Market Size by Application
  7. 5.2.1 Global Free Fatty Acid Receptor 4 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Free Fatty Acid Receptor 4 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Free Fatty Acid Receptor 4 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Free Fatty Acid Receptor 4 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Free Fatty Acid Receptor 4 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Free Fatty Acid Receptor 4 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Free Fatty Acid Receptor 4 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Free Fatty Acid Receptor 4 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Advinus Therapeutics Ltd
  2. 6.1.1 Advinus Therapeutics Ltd Company Information
  3. 6.1.2 Advinus Therapeutics Ltd Business Overview
  4. 6.1.3 Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Product Portfolio
  6. 6.1.5 Advinus Therapeutics Ltd Recent Developments
  7. 6.2 CymaBay Therapeutics Inc
  8. 6.2.1 CymaBay Therapeutics Inc Company Information
  9. 6.2.2 CymaBay Therapeutics Inc Business Overview
  10. 6.2.3 CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Product Portfolio
  12. 6.2.5 CymaBay Therapeutics Inc Recent Developments
  13. 6.3 Dompe Farmaceutici SpA
  14. 6.3.1 Dompe Farmaceutici SpA Company Information
  15. 6.3.2 Dompe Farmaceutici SpA Business Overview
  16. 6.3.3 Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Product Portfolio
  18. 6.3.5 Dompe Farmaceutici SpA Recent Developments
  19. 6.4 Sancilio & Company Inc
  20. 6.4.1 Sancilio & Company Inc Company Information
  21. 6.4.2 Sancilio & Company Inc Business Overview
  22. 6.4.3 Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sancilio & Company Inc Free Fatty Acid Receptor 4 Product Portfolio
  24. 6.4.5 Sancilio & Company Inc Recent Developments
  25. 6.5 AstraZeneca Plc
  26. 6.5.1 AstraZeneca Plc Company Information
  27. 6.5.2 AstraZeneca Plc Business Overview
  28. 6.5.3 AstraZeneca Plc Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Plc Free Fatty Acid Receptor 4 Product Portfolio
  30. 6.5.5 AstraZeneca Plc Recent Developments
  31. 6.6 GlaxoSmithKline Plc
  32. 6.6.1 GlaxoSmithKline Plc Company Information
  33. 6.6.2 GlaxoSmithKline Plc Business Overview
  34. 6.6.3 GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Product Portfolio
  36. 6.6.5 GlaxoSmithKline Plc Recent Developments
  37. 6.7 Merck & Co Inc
  38. 6.7.1 Merck & Co Inc Company Information
  39. 6.7.2 Merck & Co Inc Business Overview
  40. 6.7.3 Merck & Co Inc Free Fatty Acid Receptor 4 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co Inc Free Fatty Acid Receptor 4 Product Portfolio
  42. 6.7.5 Merck & Co Inc Recent Developments
7 North America by Country
  1. 7.1 North America Free Fatty Acid Receptor 4 Sales by Country
  2. 7.1.1 North America Free Fatty Acid Receptor 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Free Fatty Acid Receptor 4 Sales by Country (2021-2026)
  4. 7.1.3 North America Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Free Fatty Acid Receptor 4 Market Size by Country
  6. 7.2.1 North America Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Free Fatty Acid Receptor 4 Market Size by Country (2021-2026)
  8. 7.2.3 North America Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Free Fatty Acid Receptor 4 Sales by Country
  2. 8.1.1 Europe Free Fatty Acid Receptor 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Free Fatty Acid Receptor 4 Sales by Country (2021-2026)
  4. 8.1.3 Europe Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Free Fatty Acid Receptor 4 Market Size by Country
  6. 8.2.1 Europe Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Free Fatty Acid Receptor 4 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Free Fatty Acid Receptor 4 Sales by Country
  2. 9.1.1 Asia-Pacific Free Fatty Acid Receptor 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Free Fatty Acid Receptor 4 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Free Fatty Acid Receptor 4 Market Size by Country
  6. 9.2.1 Asia-Pacific Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Free Fatty Acid Receptor 4 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Free Fatty Acid Receptor 4 Sales by Country
  2. 10.1.1 South America Free Fatty Acid Receptor 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Free Fatty Acid Receptor 4 Sales by Country (2021-2026)
  4. 10.1.3 South America Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Free Fatty Acid Receptor 4 Market Size by Country
  6. 10.2.1 South America Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Free Fatty Acid Receptor 4 Market Size by Country (2021-2026)
  8. 10.2.3 South America Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Free Fatty Acid Receptor 4 Sales by Country
  2. 11.1.1 Middle East and Africa Free Fatty Acid Receptor 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Free Fatty Acid Receptor 4 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Free Fatty Acid Receptor 4 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Free Fatty Acid Receptor 4 Market Size by Country
  6. 11.2.1 Middle East and Africa Free Fatty Acid Receptor 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Free Fatty Acid Receptor 4 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Free Fatty Acid Receptor 4 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Free Fatty Acid Receptor 4 Value Chain Analysis
  2. 12.1.1 Free Fatty Acid Receptor 4 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Free Fatty Acid Receptor 4 Production Mode & Process
  7. 12.2 Free Fatty Acid Receptor 4 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Free Fatty Acid Receptor 4 Distributors
  10. 12.2.3 Free Fatty Acid Receptor 4 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst